• Western blot analysis of lysates from MCF-7 cells, using MC4R Antibody. The lane on the right is blocked with the synthesized peptide.

Anti-MC4R antibody (281-330 aa) (STJ94040)

SKU:
STJ94040

Current Stock:
Host: Rabbit
Applications: WB/IHC/IF/ELISA
Reactivity: Human/Mouse/Rat
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-Melanocortin receptor 4 (281-330 aa) is suitable for use in Western Blot, Immunohistochemistry, Immunofluorescence and ELISA research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide.
Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Concentration: 1 mg/mL
Dilution Range: WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:40000
IF 1:50-200
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MC4R
Gene ID: 4160
Uniprot ID: MC4R_HUMAN
Immunogen Region: 281-330 aa
Specificity: MC4-R Polyclonal Antibody detects endogenous levels of MC4-R protein.
Immunogen: The antiserum was produced against synthesized peptide derived from the human MC4R at the amino acid range 281-330
Function Receptor specific to the heptapeptide core common to adrenocorticotropic hormone and alpha-, beta-, and gamma-MSH. Plays a central role in energy homeostasis and somatic growth. This receptor is mediated by G proteins that stimulate adenylate cyclase (cAMP).
Protein Name Melanocortin Receptor 4
Mc4-R
Database Links Reactome: R-HSA-375276
Reactome: R-HSA-418555
Cellular Localisation Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Melanocortin Receptor 4 antibody
Anti-Mc4-R antibody
Anti-MC4R antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance